Subcutaneous Epcoritamab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Preliminary Results from the Epcore CLL-1 Trial

被引：15
|
作者：
Kater, Arnon P. [1 ]
Christensen, Jacob Haaber [2 ]
Bentzen, Hans Herluf [3 ]
Niemann, Carsten Utoft [4 ]
Hutchings, Martin [4 ]
Chen, Jenny [5 ]
Rios, Marcia [6 ]
Palenski, Tammy [6 ]
Li, Tommy [5 ]
Mato, Anthony R. [7 ]
机构：
[1] Univ Amsterdam, Amsterdam UMC, Canc Ctr Amsterdam, Amsterdam, Netherlands
[2] Odense Univ Hosp, Odense, Denmark
[3] Aarhus Univ Hosp, Aarhus, Denmark
[4] Copenhagen Univ Hosp, Rigshospitalet, Copenhagen, Denmark
[5] Genmab, Princeton, NJ USA
[6] AbbVie, N Chicago, IL USA
[7] Mem Sloan Kettering Canc Ctr, Chron Lymphocyt Leukemia Program, New York, NY USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-146563
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2627
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Epcoritamab in patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 1b/2 EPCORE CLL-1 trial expansion cohort
    Kater, Arnon
    Eradat, Herbert
    Niemann, Carsten
    Offner, Fritz
    Poulsen, Christian Bjorn
    Hoyer, Thor
    Bellido, Mar
    Shadman, Mazyar
    Oki, Toshihiko
    Kuznetsova, Alexandra
    Rios, Marcia
    Valentin, Rebecca
    Bentzen, Hans Herluf
    LEUKEMIA & LYMPHOMA, 2023, 64 : S2 - S3
  • [2] Subcutaneous Epcoritamab in Patients with Richter's Syndrome: Early Results from Phase 1b/2 Trial (EPCORE CLL-1)
    Kater, Arnon P.
    Ye, J. Christine
    Sandoval-Sus, Jose
    Bellido, Mar
    Christensen, Jacob Haaber
    Mato, Anthony R.
    Janssens, Ann
    Oki, Toshihiko
    Hoehn, Daniela
    Rios, Marcia
    Kuznetsova, Alexandra
    Valentin, Rebecca
    Eradat, Herbert
    BLOOD, 2022, 140
  • [3] Epcoritamab Induces Deep Responses in Patients With Richter Transformation (RT): Primary Results From the EPCORE CLL-1 Trial
    Kater, Arnon P.
    Janssens, Ann
    Eradat, Herbert
    Offner, Fritz
    Sandoval-Sus, Jose D.
    Shadman, Mazyar
    Poulsen, Christian Bjorn
    Christensen, Jacob Haaber
    Thompson, Meghan C.
    Rios, Marcia
    Kuznetsova, Alexandra
    Oki, Toshihiko
    Valentin, Rebecca
    Bellido, Mar
    Eichhorst, Barbara
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S350 - S351
  • [4] Subcutaneous epcoritamab plus GemOx in patients with relapsed or refractory DLBCL: Updated results from EPCORE NHL-2
    Brody, Joshua D.
    Joergensen, Judit Meszaros
    Belada, David
    Costello, Regis
    Trneny, Marek
    Vitolo, Umberto
    Lewis, David John
    Karimi, Yasmin
    Sureda, Anna
    Andre, Marc
    Wahlin, Bjorn E.
    Lugtenburg, Pieternella
    Jiang, Yajian
    Abbas, Aqeel
    Song, Yaou
    Risum, Malene
    Cordoba, Raul
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
    Odetola, Oluwatobi
    Ma, Shuo
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2023, 18 (05) : 130 - 143
  • [6] Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
    Oluwatobi Odetola
    Shuo Ma
    Current Hematologic Malignancy Reports, 2023, 18 : 130 - 143
  • [7] Subcutaneous Epcoritamab in Patients with Relapsed/ Refractory Large B-Cell Lymphoma: Longer-Term Results From the Pivotal EPCORE NHL-1 Trial
    Tatyana, Feldman
    Yasmin, Karimi
    Herve, Ghesquieres
    Wojciech, Jurczak
    Chan, Cheah Y.
    Michael, Roost Clausen
    Pieternella, Lugtenburg
    David, Cunningham
    Do Young, Rok
    John, Lewis David
    Robin, Gasiorowski
    Min, Kim Tae
    Marjolein, van der Poel
    Michelle, Limei Poon
    Kim, Linton M.
    Anna, Sureda
    Martin, Hutchings
    Mariana, Cota Stirner
    Mariana, Sacchi
    Catherine, Thieblemont
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : S49 - S50
  • [8] Subcutaneous Epcoritamab in Relapsed or Refractory Large B-Cell Lymphoma: Pivotal Results from the Phase 2 EPCORE NHL-1 Trial
    Catherine, Thieblemont
    Tycel, Phillips
    Herve, Ghesquieres
    Cheah, Chan Y.
    David, Cunningham
    Do, Young R.
    Tatyana, Feldman
    Robin, Gasiorowski Robin
    Wojciech, Jurczak
    Tae, Min Kim Tae M.
    Lewis, David J.
    Mariolein, Van der Poe
    Poon, Michelle L.
    Thomas, Doerr
    Nurgul, Kilavuz
    Menghui, Chen
    Mariana, Sacchi
    Martin, Hutchings
    Pieternella, Lugtenburg
    Roost, Clausen Michael
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S31 - S32
  • [9] Results of a phase I trial of the proteasome inhibitor carfilzomib in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL).
    Woyach, Jennifer Ann
    Flynn, Joseph M.
    Jones, Jeffrey Alan
    Andritsos, Leslie A.
    Lucas, Margaret
    Chase, Weihong
    Yang, Ying
    Lucas, David M.
    Sass, Ellen
    Waymer, Sharon
    Ling, Yonghua
    Jiang, Yao
    Phelps, Mitch A.
    Byrd, John C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Subcutaneous Epcoritamab in Patients With Relapsed or Refractory Large B-Cell Lymphoma (EPCORE NHL-1): Pivotal Results from a Phase 2 Study
    Thieblemont, Catherine
    Phillips, Tycel
    Ghesquieres, Herve
    Cheah, Chan Y.
    Clausen, Michael Roost
    Cunningham, David
    Do, Young Rok
    Feldman, Tatyana
    Gasiorowski, Robin
    Jurczak, Wojciech
    Kim, Tae Min
    Lewis, David John
    van der Poel, Marjolein
    Poon, Michelle Limei
    Doerr, Thomas
    Kilavuz, Nurgul
    Chen, Menghui
    Sacchi, Mariana
    Elliott, Brian
    Hutchings, Martin
    Lugtenburg, Pieternella
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S379 - S379
12345